| Value | ₹14.90 Cr |
|---|
BSE filing, NSE: STEELCOGUJ. Summary written from the filing by ALFA Finder's alert engine.
Steelco Gujarat Ltd: key numbers
- Share price
- ₹189.00
- Market cap
- ₹119.0 Cr
- Revenue (annual)
- ₹58.53 Cr
- Net profit (annual)
- ₹-37.27 Cr
- P/E (TTM)
- -2.5×Sector 16.5×
- Promoter holding
- 74.65%+0.00% QoQ
- FII holding
- 0.29%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Steelco Gujarat Ltd
All →Steelco Gujarat Board Meeting Date
Steelco Gujarat schedules a 4 November 2026 board meeting to approve Q2 and half-year unaudited results. Trading window closes 1 October and reopens after 6 November 2026.
Steelco Gujarat Management Change
Steelco Gujarat disclosed the resignation of Ravikant Pandey as Vice President - Operations, effective close of business 23 October 2026. The resignation email was received the same day.
Steelco Gujarat Management Change
Mr. Rajesh Kapadia's term as Independent Director of Steelco Gujarat Limited ends today, October 13, 2026. Consequently, he ceases to serve on key board committees.
Steelco Gujarat Other Announcement
The company filed its quarterly shareholding pattern for the quarter ended September 30, 2026, as required by SEBI regulations.
Steelco Gujarat Debt & Borrowing: ₹2.27 Cr
Steelco Gujarat Ltd has confirmed the interest payment of Rs. 2.27 Crore on its listed secured non-convertible debentures, ensuring compliance with its debt obligations.
- Value
- ₹2.27 Cr
Steelco Gujarat Annual General Meeting
Steelco Gujarat Limited conducted its 36th Annual General Meeting on September 25, 2026, to discuss and vote on routine and special business resolutions.
Other fund raise announcements
All →Rite Zone Chemcon India Fund Raise of ₹6.58 Cr
Rite Zone Chemcon India announced a preferential issue of 27,69,730 equity shares to 11 investors at Rs.24 each, raising about Rs.6.58 Crore. The approval awaits a shareholder vote on 23 November 2026.
- Value
- ₹6.58 Cr
Sudarshan Pharma Industries Fund Raise of ₹72 Cr
Sudarshan Pharma's board approved up to Rs. 72 Crore of preferential convertible warrants for promoters Hemal and Sachin Mehta. Shareholder approval will be sought at an EGM.
- Value
- ₹72.00 Cr
Flywings Simulator Training Centre Fund Raise of ₹68.2 Cr
Flywings Simulator's board approved Rs. 68.20 Crore fully convertible warrants on a preferential basis. Promoter Rupal Mandavia is allotted Rs. 25 Crore, subject to shareholder approval.
- Value
- ₹68.20 Cr
Kanel Industries Fund Raise of ₹16.99 Cr
Kanel Industries' board approved a rights issue of 42.52 lakh equity shares at Rs.39.95 each. The issue aggregates about Rs.16.99 Crore, with record date 13 November 2026.
- Value
- ₹16.99 Cr
- Execution
- Rights issue opens 23 November 2026 and closes 30 November 2026
Sudarshan Pharma Industries Fund Raise
Board approved issuing up to 72 Crore warrants to promoters on a preferential basis. Pricing per Reg 164 is pending, with no fixed rupee value stated.
GAIL (India) Fund Raise
GAIL Board approved in principle the IPO of subsidiary GAIL Gas Limited on Indian exchanges. GAIL will dilute its GGL equity up to 25%.